Production (Stage)
PharmaRoth Labs, Inc.
ROTH
$0.00
$0.000.00%
OTC PK
| 03/31/2011 | 12/31/2010 | 09/30/2010 | 06/30/2010 | 03/31/2010 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 0.00 | -- | -- | -- | -- |
| Total Receivables | 94.80K | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -- | 32.80K | 28.00K | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 94.80K | 32.80K | 28.00K | -- | -- |
|
|
|||||
| Total Current Assets | 94.80K | 32.80K | 28.00K | -- | -- |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 94.80K | 32.80K | 28.00K | -- | -- |
|
|
|||||
| Total Accounts Payable | 79.40K | 28.80K | 19.30K | 6.20K | 25.40K |
| Total Accrued Expenses | 8.30K | 5.80K | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 250.00K | 358.00K | 314.30K | -- | 12.50K |
| Total Finance Division Other Current Liabilities | 52.40K | -- | -- | -- | -- |
| Total Other Current Liabilities | 52.40K | -- | -- | -- | -- |
| Total Current Liabilities | 390.10K | 392.60K | 333.60K | 6.20K | 37.90K |
|
|
|||||
| Total Current Liabilities | 390.10K | 392.60K | 333.60K | 6.20K | 37.90K |
| Long-Term Debt | -- | -- | -- | 286.30K | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 390.10K | 392.60K | 333.60K | 292.40K | 37.90K |
|
|
|||||
| Common Stock & APIC | 416.90K | 246.60K | 246.60K | 127.50K | 36.60K |
| Retained Earnings | -712.10K | -606.40K | -552.20K | -329.00K | -74.50K |
| Treasury Stock & Other | -- | -- | -- | -90.90K | -- |
| Total Common Equity | -295.30K | -359.80K | -305.60K | -292.40K | -37.90K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -295.30K | -359.80K | -305.60K | -292.40K | -37.90K |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -295.30K | -359.80K | -305.60K | -292.40K | -37.90K |
|
|
|||||